Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04285476 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type

Study acronym: PREDICYTHY
StatusActive, Not Recruiting
PhaseNot applicable
Started2021-06-17
View on ClinicalTrials.gov ↗
The aim is to validate a signature of microRNA (micro Ribonucleic acid) based in a first exploratory study allowing the stratification of the cytologies of indeterminate type and to study and select others. In a first step, the teams will focus on standardising the pre-analytical stages and defining a threshold of positivity. The results of microRNA signature on a cohort of 70 patients will be compared with the ultrasound and then histological data of the resection specimen.

Amendment history 1 change detected by DataLookout

2026-09-15
Primary completion pushed: 2026-07 → 2026-12
Trial Details
NCT Number NCT04285476
Lead Sponsor Institut du Cancer de Montpellier - Val d'Aurelle
Conditions Thyroid Cancer
Enrollment 71 participants
Start Date 2021-06-17
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-09-14